Key statistics
As of last trade, Faron Pharmaceuticals Oy (4FR:FRA) traded at 1.66, 59.54% above the 52 week low of 1.04 set on Jun 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.66 |
---|---|
High | 1.66 |
Low | 1.66 |
Bid | 1.67 |
Offer | 1.69 |
Previous close | 1.72 |
Average volume | 0.00 |
---|---|
Shares outstanding | 104.62m |
Free float | 71.34m |
P/E (TTM) | -- |
Market cap | 148.85m GBP |
EPS (TTM) | -0.3161 GBP |
Data delayed at least 15 minutes, as of Nov 22 2024 07:17 GMT.
More ▼
Announcements
- Targeting Soluble Clever-1 for Autoimmune Diseases
- Shareholders’ Nomination Board
- Faron’s Capital Markets Day 2024
- Faron announces Capital Markets Day
- Grant of options
- Faron 2024 Half-Year Financial Results
- FDA Grants Fast Track Designation for Bexmarilimab
- Notice of Half-Year Financial Results
- Traumakine Research Collaboration and DoD Grant
- Appointment of Chief Financial Officer
More ▼